Home › Funds › Eiger Wealth Management, LLC › IMNM
Eiger Wealth Management, LLC position in IMNM
Immunome Inc · Health Care
Eiger Wealth Management, LLC reported holding 10,587 shares of IMNM (Immunome Inc) in its Q3 2026 13F filing — a position valued at US$228K, representing 4.93% of its reported portfolio and ranking #10 among its reported holdings. Eiger Wealth Management, LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How Eiger Wealth Management, LLC's IMNM position evolved
Eiger Wealth Management, LLC first disclosed a stake in IMNM in Q4 2025 at 13,647 shares (US$293K). The position peaked in Q1 2026 at 13,647 shares, worth US$298K. Across 4 filings, Eiger Wealth Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,587 shares valued at US$228K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 13.65K | $293.14K | New |
| Q1 2026 | 13.65K | $298.46K | Hold |
| Q2 2026 | 10.59K | $224.34K | Reduce |
| Q3 2026 | 10.59K | $227.73K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMNM and 13F data
IMNM (Immunome Inc) is a Health Care company. 49 other funds we track also report a position in IMNM — the largest reported positions include Redmile Group, LLC (US$104.1M), Enavate Sciences GP, LLC (US$76.6M), SILVERARC CAPITAL MANAGEMENT, LLC (US$42.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMNM
- Redmile Group, LLC 4.91M sh · $104.08M · Q2 2026
- Enavate Sciences GP, LLC 3.61M sh · $76.58M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.02M sh · $42.74M · Q2 2026
- Sofinnova Investments, Inc. 1.72M sh · $36.45M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 1.61M sh · $34.03M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 732.51K sh · $15.52M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 714.55K sh · $15.14M · Q2 2026
- Parkman Healthcare Partners LLC 594.20K sh · $12.59M · Q2 2026
- ALERUS FINANCIAL NA 383.42K sh · $8.12M · Q2 2026
- Atom Investors LP 297.49K sh · $6.30M · Q2 2026
More on Eiger Wealth Management, LLC
FAQ
How long has Eiger Wealth Management, LLC held IMNM?
Eiger Wealth Management, LLC has disclosed IMNM holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Eiger Wealth Management, LLC's current position in IMNM?
As of Q3 2026, Eiger Wealth Management, LLC holds 10.59K shares of IMNM (Immunome Inc), valued at $227.73K, representing 4.93% of its reported portfolio and ranking #10.
Has Eiger Wealth Management, LLC been buying or selling IMNM?
In the latest 13F filing (Q3 2026), Eiger Wealth Management, LLC held unchanged its position in IMNM. The position peaked in Q1 2026 at 13.65K shares.
Which other funds hold IMNM?
Other major institutional holders of IMNM include Redmile Group, LLC, Enavate Sciences GP, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.